• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

AbbVie (ABBV) Tops Q3 Earnings Estimates

cafead

Administrator
Staff member
  • cafead   Oct 29, 2021 at 11:12: AM
via AbbVie (ABBV Quick QuoteABBV - Free Report) came out with quarterly earnings of $3.33 per share, beating the Zacks Consensus Estimate of $3.23 per share. This compares to earnings of $2.83 per share a year ago. These figures are adjusted for non-recurring items.

article source